Journal of Vascular and Interventional Radiology
Volume 21, Issue 4 , Pages 490-495 , April 2010

Leiomyoma Volume Changes at Follow-up after Uterine Artery Embolization: Correlation with the Initial Leiomyoma Volume and Location

Received 29 January 2009 ,Revised 8 November 2009 ,Accepted 1 December 2009.

References 

  1. Pinto I, Chimeno P, Romo A, et al. Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment—a prospective, randomized, and controlled clinical trial. Radiology. 2003;226:425–431
  2. Greenberg MD, Kazamel TI. Medical and socioeconomic impact of uterine fibroids. Obstet Gynecol Clin North Am. 1995;22:625–636
  3. Friedman AJ, Hoffman DI, Comite F, Browneller RW, Miller JD. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study (The Leuprolide Study Group). Obstet Gynecol. 1991;77:720–725
  4. Matta WH, Shaw RW, Nye M. Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserilin. Br J Obstet Gynecol. 1989;96:200–206
  5. Heaston DK, Mineau DE, Brown BJ, Miller FJ. Transcatheter arterial embolization for control of persistent massive puerperal hemorrhage after bilateral surgical hypogastric artery ligation. AJR Am J Roentgenol. 1979;133:152–154
  6. Pelage JP, Le Dref O, Mateo J, et al. Life-threatening primary post partum haemorrhage: treatment with emergency selective arterial embolisation. Radiology. 1998;208:359–362
  7. Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolization to treat uterine myomata. Lancet. 1995;346:671–672
  8. Goodwin SC, Vedantham S, McLucas B, Forno AE, Perrella R. Preliminary experience with uterine artery embolization for uterine fibroids. J Vasc Interv Radiol. 1997;8:517–526
  9. Bradley EA, Reidy JF, Forman RG, Jarosz J, Braude PR. Transcatheter uterine artery embolisation to treat large uterine fibroids. Br J Obstet Gynaecol. 1998;105:235–240
  10. Exacoustos C, Rosati P. Ultrasound diagnosis of uterine myomas and complications in pregnancy. Obstet Gynaecol. 1993;82:97–101
  11. Bukulmez O, Doody KJ. Clinical features of myomas. Obstet Gynecol Clin North Am. 2006;33:69–84
  12. Gambone JC, Reiter RC, Lench JB, Moore JG. The impact of a quality assurance process on the frequency and confirmation rate of hysterectomy. Am J Obstet Gynecol. 1990;163:545–550
  13. Pelage JP, Le Dref O, Soyer P, et al. Fibroid-related menorrhagia: treatment with superselective embolization of the uterine arteries and midterm follow-up. Radiology. 2000;215:428–431
  14. Verma SK, Bergin D, Gonsalves CF, Mitchell DG, Lev-Toaff AS, Parker L. Submucosal fibroids becoming endocavitary following uterine artery embolization: risk assessment by MRI. AJR Am J Roentgenol. 2008;190:1220–1226
  15. Sterling KM, Siskin GP, Ponturo MM, Mandato K, Rholl KS, Cooper JM. A multi-center study evaluating the use of Gelfoam only for uterine artery embolization for symptomatic leiomyomata (abstr.). J Vasc Interv Radiol. 2002;13(Suppl):S19
  16. Katsumori T, Nakajima K, Mihara T, Tokuhiro M. Long-term outcomes of uterine artery embolization using gelatin sponge particles alone for symptomatic fibroids: midterm results. AJR Am J Roentgenol. 2002;178:135–139
  17. Worthington-Kirsch RL, Popky GL, Hutchins FL. Uterine arterial embolization for the management of leiomyomas: quality of life assessment and clinical response. Radiology. 1998;208:625–629
  18. Lipman JC. Uterine artery embolization for the treatment of symptomatic uterine fibroids: a review. Appl Radiol. 2000;20:15–20
  19. Machan L, Goodwin S, Worthington-Kirsch R, Spies R. Fibroid embolization: periprocedural care. Semin Interv Radiol. 2000;17:247–254
  20. Bucek RA, Puchner S, Lammer J. Mid- and long-term quality-of-life assessment in patients undergoing uterine fibroid embolization. AJR Am J Roentgenol. 2006;186:877–882
  21. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility, 7th ed. PhiladelphiaLippincott Williams & Wilkins. 2005;115–116
  22. Spies JB, Benenati JF, Worthington-Kirsch RL, Pelage JP. Initial experience with use of tris-acryl gelatin microspheres for uterine artery embolization for leiomyomata. J Vasc Interv Radiol. 2001;12:1059–1063
  23. Katsumori T, Nakajima K, Tokuhiro M. Gadolinium-enhanced MR imaging in the evaluation of uterine fibroids treated with uterine artery embolization. AJR Am J Roentgenol. 2001;177:303–307
  24. Marret H, Alonso AM, Cottier JP, Tranquart F, Herbreteau D, Body G. Leiomyoma recurrence after uterine artery embolization. J Vasc Interv Radiol. 2003;14:1395–1399
  25. Katsumori T, Nakajima K, Mihara T. Is a large fibroid a high-risk factor for uterine artery embolization?. AJR Am J Roentgenol. 2003;181:1309–1314
  26. Spies JB, Roth AR, Jha RC, et al. Leiomyomata treated with uterine artery embolization: factors associated with successful symptom and imaging outcome. Radiology. 2002;222:45–52

 None of the authors have identified a conflict of interest.

PII: S1051-0443(09)01659-5

doi: 10.1016/j.jvir.2009.12.388

Journal of Vascular and Interventional Radiology
Volume 21, Issue 4 , Pages 490-495 , April 2010

Article Tools

* Image Usage & Resolution